InnoCan Pharma Launches Trading on OTCQB Venture Market InnoCan Pharma has officially launched common shares trading on the OTCQB Venture Market, placing the promising pharmaceuticals company in the next stage of its strategic commercialization plan
Stay informed and join our daily newsletter now!
Email May 24, 2021 5 min read Opinions expressed by
Entrepreneur contributors are their own.
As many countries around the world vaccinate and begin to end restrictions on wearing masks outdoors, InnoCan Pharma is expected to continue its current pattern of steady growth. Since the start of the new year, major stock indexes including the Dow Jones, S&P and NASDAQ have already regained a great deal of their COVID-era losses. Now is the time that stock traders and investors are keeping a keen eye on emerging companies entering the market, especially biotechnology companies that adapted due to the pandemic and prospered last year.
Entera Announces Ron Mayron, a Global Pharma Leader, Joins its Board of Directors
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.
Kadimastem hopes to turn corner with new management
The Israeli stem cell technology company has named Asaf Shiloni CEO, after three new expert directors joined its board.
Israeli stem cell technology company Kadimastem (TASE: KDST) has had a chequered history, with frequent going concern warnings on its financials, a downward drifting share price from its 2016 peak, and the departure last year of founder and CEO Yossi Ben-Yosef. The company now hopes to have turned a corner with the appointment of a new and experienced CEO and new directors.
Kadimastem has named Asaf Shiloni, who was Vice President of Sales and Business Development at California-based PeproTech Inc., as CEO. PeproTech is the leading manufacturer of GMP Cytokines, vital components in all stem cell and cell therapy clinical trials. Kadimastem s announcement states that at PeproTech Shiloni established collaborations and joint ventures with top US stem cell companies and leading research labs worldwide, and also led
Kadimastem Announces Executive Management Changes
USA - English
Accomplished US Life Science and Biotech Executive Asaf Shiloni Named New CEO
Company Appoints Biotech Industry Leaders Ronen Twito, CPA as Co-Chairperson and Doron Birger and Ron Mayron to the Company s Board of Directors
News provided by
Share this article
NESS ZIONA, Israel, Feb. 1, 2021 /PRNewswire/
Kadimastem Ltd. (TASE: KDST), a clinical stage cell therapy company, announces the appointment of Asaf Shiloni as CEO. This follows a series of executive management appointments in the last month including Mr. Ronen Twito, CPA, as Co-Chairperson of Kadimastem s Board of Directors, and new expert Board members, Mr. Doron Birger and Mr. Ron Mayron. All are highly accomplished biotechnology industry experts, dedicated to working in concert to secure a bright future for the company.